Since December 2019, there has been an outbreak of a novel beta-coronavirus (SARS-CoV-2) in Wuhan, China. On March the 11th the World Health Organization (WHO) declared COVID-19 as a pandemic, with over 118,000 cases in more than 110 countries around the world. In response to the global coronavirus disease 2019 (COVID-19) emergency, clinical trial research assessing the efficacy and safety of experimental vaccines to prevent COVID-19 are emerging at an unprecedented rate. The aim of this systematic review is to summarize the preliminary experiences and ongoing clinical trials of the major candidates and challenges of the vaccine strategies in humans.
The vaccine journey for COVID-19: a comprehensive systematic review of current clinical trials in humans / Checcucci, Enrico; Piramide, Federico; Pecoraro, Angela; Amparore, Daniele; Campi, Riccardo; Fiori, Cristian; Elhage, Oussama; Kotecha, Pinky; Vyakarnam, Annapurna; Serni, Sergio; Dasgupta, Prokar; Porpiglia, Francesco. - In: PANMINERVA MEDICA. - ISSN 0031-0808. - ELETTRONICO. - (2020), pp. 0-0. [10.23736/S0031-0808.20.03958-0]
The vaccine journey for COVID-19: a comprehensive systematic review of current clinical trials in humans
Campi, Riccardo;Serni, Sergio;
2020
Abstract
Since December 2019, there has been an outbreak of a novel beta-coronavirus (SARS-CoV-2) in Wuhan, China. On March the 11th the World Health Organization (WHO) declared COVID-19 as a pandemic, with over 118,000 cases in more than 110 countries around the world. In response to the global coronavirus disease 2019 (COVID-19) emergency, clinical trial research assessing the efficacy and safety of experimental vaccines to prevent COVID-19 are emerging at an unprecedented rate. The aim of this systematic review is to summarize the preliminary experiences and ongoing clinical trials of the major candidates and challenges of the vaccine strategies in humans.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
